Phorbol ester inhibition of hormonal induction of tyrosine aminotransferase

Insights

Phorbol esters inhibit the liver enzyme tyrosine aminotransferase induction by insulin, glucocorticoids, and cAMP. This suggests a common pathway for these inducers, contrary to previous beliefs.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Tyrosine aminotransferase is a liver-specific enzyme.
  • Glucocorticoids, cAMP analogs, and insulin induce tyrosine aminotransferase via separate pathways.
  • Phorbol esters are known to inhibit insulin's induction of this enzyme by affecting the insulin receptor.

Purpose of the Study:

  • To investigate the effect of TPA (12-O-tetradecanoylphorbol-13-acetate) on tyrosine aminotransferase induction.
  • To determine if TPA affects induction by agents other than insulin.

Main Methods:

  • Enzyme assays to measure tyrosine aminotransferase activity.
  • Treatment of liver cells with TPA, insulin, glucocorticoids, and cAMP analogs.

Main Results:

  • TPA inhibited insulin-stimulated tyrosine aminotransferase induction.
  • TPA also inhibited tyrosine aminotransferase induction by glucocorticoids.
  • TPA inhibited tyrosine aminotransferase induction by cAMP analogs.

Conclusions:

  • TPA inhibits tyrosine aminotransferase induction by multiple agents.
  • These findings suggest a potential convergence or common regulatory mechanism for these induction pathways.
  • This challenges the established model of separate pathways for insulin, glucocorticoid, and cAMP induction.

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...